DIM
IDYA icon

DC Investments Management’s IDEAYA Biosciences IDYA Stock Holding History

DC Investments Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-53,620
Closed -$534K – 326
2019
Q2 		$534K Buy
+53,620
New +$583K 0.3% 139

Other funds holding IDYA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DC Investments Management's IDYA Position: Q3 2019 in Review

DC Investments Management sold out of IDEAYA Biosciences (IDYA) in Q3 2019, closing a stake of 53,620 shares — an estimated $534K sold.

DC Investments Management first reported a position in IDYA in Q2 2019 and held it in 1 quarter. The position peaked at $534K in Q2 2019. 24 funds tracked by Wall St. Rank hold IDYA as of Q3 2019.

  • DC Investments Management reported no remaining IDEAYA Biosciences position as of Q3 2019 after selling out during the quarter.
  • DC Investments Management sold 53,620 IDEAYA Biosciences shares in Q3 2019, an estimated $534K.
  • DC Investments Management first reported a position in IDEAYA Biosciences in Q2 2019 and held it in 1 quarter.
  • DC Investments Management's IDEAYA Biosciences position peaked at $534K in Q2 2019.
  • 24 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2019.

Based on DC Investments Management's 13F filing for Q3 2019, filed 5 Nov 2019.